Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 10(1): 18509, 2020 10 28.
Article in English | MEDLINE | ID: mdl-33116163

ABSTRACT

The potential therapeutic effects of molecular hydrogen (H2) have now been confirmed in various human and animal-disease models. However, the effects of H2 on the physiological function in a normal state have been largely neglected. Hydrogen-rich water (HRW) intake and hydrogen inhalation (HI) are the most common used methods for hydrogen administration, the difference in the effects between HRW intake and HI remains elusive. In the present study, the body weight and 13 serum biochemical parameters were monitored during the six-month hydrogen intervention, all these parameters were significantly altered by oral intake of HRW or HI. Among the 13 parameters, the most striking alterations induced by hydrogen treatment were observed in serum myocardial enzymes spectrum. The results also showed that the changes in these parameters occurred at different time points, and the alterations in most of the parameters were much more significant in HI than HRW. The results of this study provides the basic data for the mechanism research and application of molecular hydrogen in the future.


Subject(s)
Hydrogen/pharmacology , Rats/physiology , Animals , Blood Glucose/drug effects , Body Weight/drug effects , China , Disease Models, Animal , Heart/drug effects , Hydrogen/administration & dosage , Hydrogen/metabolism , Liver/metabolism , Male , Myocardium/metabolism , Oxidative Stress/drug effects , Rats, Sprague-Dawley , Triglycerides/analysis , Uric Acid/analysis , Uric Acid/blood , Water/chemistry
2.
Brain Res ; 1748: 147053, 2020 12 01.
Article in English | MEDLINE | ID: mdl-32814064

ABSTRACT

Traumatic brain injury (TBI) is a major cause of mortality and disability worldwide. To date, therapies to treat any forms of TBI are still limited. Recent studies have demonstrated the potential neuroprotective effects of molecular hydrogen on TBI. Although it has been demonstrated that hydrogen inhalation (HI) for about 5 hrs immediately after TBI has a beneficial effect on brain injury, the most effective intervention procedure in the treatment of TBI remains unknown. The mechanism underlying the neuroprotective effects of HI on TBI also needs to be further investigated. Our results showed that inhalation of 4% hydrogen during the first day after TBI was the most effective hydrogen intervention procedure in the treatment of TBI. Pathological examination showed that HI could attenuate TBI-induced reactive astrocytosis and microglial activation. Nissl staining demonstrated a significant decrease in the number of nissl-stained dark neurons (N-DNs) in HI group compared to TBI group at 2 h post-TBI, and the TBI-induced neuronal loss was attenuated by HI at day 3 post-TBI. IHC staining showed that HI resulted a decrease in CD16-positive cells and a further increase in CD206-positive cells as compared to TBI group. Multiplex cytokine assay demonstrated the most profound regulatory effects induced by HI on the levels of IL-12, IFN-γ, and GM-CSF at 24 h post-TBI, which confirmed the inhibitory effect of hydrogen on microglia activation. We concluded that inhalation of 4% hydrogen during the first day after TBI was the most effective intervention procedure in the treatment of TBI. Our results also showed that hydrogen may exert its protective effects on TBI via inhibition of microglia activation and neuroinflammation.


Subject(s)
Brain Injuries, Traumatic/metabolism , Brain/drug effects , Hydrogen/pharmacology , Inflammation/metabolism , Microglia/drug effects , Neuroprotective Agents/pharmacology , Animals , Brain/metabolism , Brain/pathology , Brain Injuries, Traumatic/drug therapy , Brain Injuries, Traumatic/pathology , Disease Models, Animal , Hydrogen/therapeutic use , Inflammation/drug therapy , Inflammation/pathology , Male , Microglia/metabolism , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Neuroprotective Agents/therapeutic use , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...